))
Episode 56: Jason Bock- Founder and CEO at CTMC
Manage episode 404807783 series 3526490
Content provided by Vial. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vial or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Step into the future as Dr. Jason Bock, founder and CEO of CTMC discusses the company's unique approach to accelerating cell therapies from development to testing, and the power of collaboration in reshaping the future of cancer treatment. Listen in as we discuss how CTMC's partnership with MD Anderson is not just technical but deeply human in nature, with the patient and personalized medicine at heart
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.
Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials
Chapters
1. Episode 56: Jason Bock- Founder and CEO at CTMC (00:00:00)
2. Accelerating Cell Therapies (00:00:07)
3. Revolutionizing Cancer Treatment With Cell Therapy (00:09:11)
62 episodes
Share
